{"id":263654,"date":"2026-09-23T11:11:19","date_gmt":"2026-09-23T05:41:19","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=263654"},"modified":"2026-09-23T11:11:19","modified_gmt":"2026-09-23T05:41:19","slug":"arvee-laboratories-india-best-stock-in-its-sector","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/arvee-laboratories-india-best-stock-in-its-sector\/","title":{"rendered":"Is Arvee Laboratories India the Best Stock in Its Sector? A Look at the Numbers"},"content":{"rendered":"

Arvee Laboratories India CMP Rs 236 (23 Sep 2026). Market cap Rs 260 Cr. ROE 7.48%. P\/E 64.15x versus Industry P\/E 40.34x.<\/em><\/p>\n

\n

Quick Answer<\/strong><\/p>\n

Arvee Laboratories India is one of the names investors compare when screening the Healthcare sector, built on a 7.48% return on equity and a P\/E of 64.15x against an Industry P\/E of 40.34x. Whether Arvee Laboratories India is the best stock in its sector depends on whether an investor is optimising for return ratios, valuation, or both. This article breaks down the metrics, including a comparison against named Healthcare sector peers, so you can judge that for yourself.<\/p>\n<\/p><\/div>\n

Is Arvee Laboratories India<\/a> the best stock in its sector? The stock trades on the NSE at Rs 236 as of 23 September 2026, within its 52-week range of Rs 129.11 to Rs 290.78. Arvee Laboratories (India) Ltd manufactures nutraceutical and pharmaceutical formulations.<\/p>\n

Arvee Laboratories India sits in the Healthcare sector, and its 7.48% ROE and 64.15x P\/E give a starting point for judging where it stands against comparable listed names. The rest of this article compares those numbers against verified peers and the sector’s Industry P\/E benchmark.<\/p>\n

Also read – Is Abbott India the Best Stock in Its Sector? A Look at the Numbers<\/a><\/p>\n

Click Here – Get Free Investment Predictions<\/strong><\/a><\/p>\n

\n
\n

Table of Contents<\/p>\nToggle<\/span><\/path><\/svg><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n